Last reviewed 2026-04-19 · How we verify

Nifedlipine

MemorialCare · discontinued Small molecule

Nifedlipine is a Small molecule drug developed by MemorialCare. It is currently in discontinued development.

At a glance

Generic name	Nifedlipine
Sponsor	MemorialCare
Modality	Small molecule
Therapeutic area	Other
Phase	discontinued

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Randomized Trial of Oral Nifedipine Versus Intravenous Magnesium Sulfate in the Acute Management of Preterm Labor in Women With Singleton Gestations, Intact Fetal Membranes, and Positive Vaginal Fet (Phase 3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Nifedlipine CI brief — competitive landscape report
Nifedlipine updates RSS · CI watch RSS
MemorialCare portfolio CI

Frequently asked questions about Nifedlipine

What is Nifedlipine?

Nifedlipine is a Small molecule drug developed by MemorialCare.

Who makes Nifedlipine?

Nifedlipine is developed by MemorialCare (see full MemorialCare pipeline at /company/memorialcare).

What development phase is Nifedlipine in?

Nifedlipine is in discontinued.

Manufacturer: MemorialCare — full pipeline
Therapeutic area: All drugs in Other

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing